Latest Articles

Publication Date
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY

Published: Nov. 25, 2025, 2:06 p.m.
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer - NAVLIN DAILY

HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer NAVLIN DAILY

Published: Nov. 24, 2025, 12:18 p.m.
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer - Oncodaily

Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer Oncodaily

Published: Nov. 21, 2025, 4:19 p.m.
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - This is Money

GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug This is Money

Published: Nov. 21, 2025, 11:48 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - springermedicine.com

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression springermedicine.com

Published: Nov. 21, 2025, 2:26 a.m.
What Is the Role of ctDNA in Ovarian and Endometrial Cancers? - ASCO Daily News

What Is the Role of ctDNA in Ovarian and Endometrial Cancers? ASCO Daily News

Published: Nov. 21, 2025, 2:24 a.m.
Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report - Cureus

Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report Cureus

Published: Nov. 21, 2025, 1:57 a.m.
Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors - Nature

Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors Nature

Published: Nov. 19, 2025, 2:27 p.m.
Endometrial Cancer Risk Models: Insights and Limits - Bioengineer.org

Endometrial Cancer Risk Models: Insights and Limits Bioengineer.org

Published: Nov. 19, 2025, 2:21 p.m.
The effect of para-aortic lymphadenectomy on survival in early stage endometrioid grade 3 and non-endometrioid endometrial cancers - BMC Women's Health

The effect of para-aortic lymphadenectomy on survival in early stage endometrioid grade 3 and non-endometrioid endometrial cancers BMC Women's Health

Published: Nov. 19, 2025, 11:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!